Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dwudman, you have been very quiet lately. Any thoughts?
Seriously speaking, before selling we have to know what are we selling.
Jonathan, I still don't know IT until you show IT to us and proof IT.
The same goes for buyers if any.
Will be glad with 5c more every day for the next 365.
Would be happy with 10c and delighted with 15c.
SO, JONATHAN, TRICK OR TREAT?
I will take $20 today in cash offer.
I'm starting with asking $50, but I would take ...
...VERIFIABLE NEWS FIRST.
According to him you have to wait till Friday for anything.
Sorry Lloyd.
Doc your input is always important to me. Thanks for PYPR again.
Doc, I can only speculate here, but may be he just got a much better deal at the meeting than he expected. Will see.
It was my response to JB:
"Hi Jonathan,
w/o details it's very difficult to decide which offer is better.
According to you future looks very promising, but we had "promising" 1.5 years already.
From another side share holders are so much down in PPs so the "quick profit" could still leave us with a huge loss.
I personally would prefer delivering contracts and long term holding as I expected the company to be.
The buyout should be more appropriate at $50 or higher.
The very best wishes!!!"
Jonathan wanted inputs from everyone, but I would prefer to see THE NEWS first.
Better luck tomorrow.
JB:
"This will kick off the news delivered by our partners. The only major decision we have to make and one quickly, is when the news hits as has been intimated, would the share holders prefer us to take the first realistic offer to buy out and make a quick profit or do we follow the plan and deliver a large Global Corp? In my opinion both offers ha there benefits and both offers would be available to us!
Imagine the possible scenario, a little company like Medify secures and delivers national contract, bearing in mind these contracts as per the norm are granted for 5 to 10 years. Thus it does not take rocket science to predict that we would be a perfect target for the larger companies and corps in our market.
Within the UK the perceived news is already being talked about openly and yesterdays events when there was a serious attempt to take the pps as low as possible I believe was not just coincidence.
So all I can say is that I am 100% confident of the future in terms of delivering the contracts. What these kind of announcements bring out of the wood work is anyone's guess and it is now a question in my opinion as to whether we take a quick buck or make several?"
Jonathan.
I proposed to him a buyout at $50 or higher.
The thanks was from me.
Me: How was the meeting? Is it over?
Jonathan:
Much much better than could be expected.
No bull, no optimism, just fact that the end game has been brought forward.
No thanks needed it is what we have all worked for. The stress is I can't tell the investors yet. When this starts going in the right direction, I will forward split and return the status quo and we will all be happy. This is huge news, and ahead of schedule. The team deserve an big thanks from me and that includes the loyal share holders such as your self.
Congrats, we made through another day w/o loss. Still believe in this week. GO JOHNY GO!!!
Just added half mil here. Should make me money.
No, this just Medify disguise their product. Good work JB.
Cool down, please.
Lem, GOLD time, that I'm Solidgold after all.
I have a good FEELING for this week.
Tomorrow is another day.
Lloyd, after all you have been through can you wait a couple of more days for conclusions? I'm in a deeper s...t than the most of you, but I can wait another week. What else is left?
Very good point, and this big contract should come by next month from Japan. IMHO
Hold on, we will know pretty soon now.
Thank you all for your kind words. We are all in this together.
GO JOHNY GO!!!
Just do my job.
Sherlock
Continuation from JB:
Me: "Thanks,
Anything else ?
How about "huge news" that should be in by now?
Is Extraordinary Dividend still alive?
Asian Dividend by Christmas ?
Italian pilot?
Spain?
Germany?
Anything that will move PPS up?"
JB: "It is all lined up I just need the first step approved and then all will flow as per my plan. I apologise for the delay in getting there but we have definitely arrived. The news is out of my hands in terms of timing as it is coming form our customers."
Just from JB:
"How can I put this. I have no idea why the pps has dropped. We are at a meeting with the NHS and EMIS tomorrow as quoted in the public domain. There are only two reasons why we are going, MedifyRemote availability to EMIS and the NHS."
Blazedhorseman, this is from your post #558 on SUF board:
"We just needed a stop to the bleeding to give people an idea of where the bottom or begginning of a new range will begin.
I dont want to get ahead of myself but this could be the opportunnity of a lifetime right before our eyes and only time will tell. "
"We have been up, we have been down but we are not out. That is most important.
Blazed
Blazedhorse"
OI KAK STRASHNO!!!
Clancy, here is from my last e-mail to JB:
"PLEASE GIVE US GOOD NEWS!
And don't promise any more if you can't deliver in time."
Good luck to you.
4Godnmv, thank you for all updates!!!
My Dear Medifyers,
I will try to answer all of you in reference to Jonathan's e-mails.
I do appreciate getting them from him, otherwise we all simply don't have enough information from just a few not quite accurate PRs issued by the company.
I don't know why he chose to answer my e-mails ( but not all of them just a few select ones), but I hope it's because with all my criticism, and believe me I send enough of it, I always underline my very best wishes for JB, for the company and for us all.
He does not answer all of my emails, but I view his replies from the perspective of all of my answered and unanswered e-mails. Some people became very and unjustifiably critical to me for sending my e-mails to JB and to him for responding to them. This is why I decided to post just what I decided to post still having both our's and company's interests in mind. I promise to you my honesty and integrity, and it is up to you to believe or not to believe me.
ALWAYS DO YOUR OWN DD AND DO NOT RELAY ONLY ON INFORMATION POSTED ON THIS BOARD!!!
With my respect to all of you,
Solidgold
It was a great day, but still the beginning.
I'm not one of these five, but I roar for my shares and for RUSHNET. VERY GOOD NEWS today!!!
O/T: In my post 10646 I was positive on RSHN and I'm still very much so. Today's late news are VERY encouraging. Very good buy for the short and long holdings (my average is still higher).IMHO
Also feel much better today after exchanging e-mails with JB. We did quite an exchange and he was responding right away.
GO JOHNY GO!!!
Thanks Doc, even I'm in green in PYPR today. Don't have as many shares as you so.LOL
GOOD LUCK!!!
I'm not sure any more if I should post it or not.
Some of you are twisting my words now.
But here is some of what I just got from JB.
It is up to you to think about this anything you want, but I post it for some people who trust me.
This board is getting very agly.
But here is from JB:
"The German site going live is the start of the next phase for Medify. I DO NOT want any more mistakes because I am trying to help and support the company and its shareholders. I try to share my enthusiasm which is taken out of context and then used against me. But the end game has begun and will be demonstrated by our partners shortly.
Maybe www.medifysolutions.de will put a smile on your face?"
Good luck to all!
Trinity, I would like to be optimistic, but what does it have to do with Medify? Please don't give me any more b.s. from J.B., I got enough of it from his e-mails to me.
Yes, and every week has Monday/Friday. A delay for what?
The main factor for me is that where is no verification by the 3rd party of anything positive and Medify. At this point I have no value for any of Jonathan's predictions.
Border control
26 Oct 2006
Neil Versel
There are some who think that cross-European interoperability will promote high-quality, efficient care between institutions and across national frontiers. But other evidence and opinions suggest that it is only one step along a challenging path.
Nevertheless, the topic is gaining more and more attention - an interoperability showcase from the international Integrating the Healthcare Enterprise (IHE) project was a centrepiece of this month's World of Health IT conference and exhibition in Geneva.
“I think the idea of having interoperability across borders in Europe is a noble one, but it’s light years away,” says Murray Bywater, managing director of Hampshire-based Silicon Bridge Research. “A lot of the perceived wisdoms in this area are just plain wrong. They’re just fantasy.”
“It’s a seriously, seriously difficult challenge. It’s not just a technical challenge, it’s an operational challenge.”
Standardisation in any large industry is a long process, perhaps 10 years or more, and healthcare tends to move more slowly than most. “The question is: What do you use in the meantime?” Bywater says.
There is an adage in the US: 'Don’t let perfection be the enemy of progress.' The phrase, often attributed to internationally known patient safety advocate Dr Donald Berwick and frequently invoked by former US national health IT co-ordinator Dr David Brailer, certainly can apply to many European health systems.
A more pragmatic approach than aiming for a comprehensive, pan-European health record would be to narrow the focus to specific health communities, such as a local population or a group of patients with diabetes, Bywater suggests.
Bywater says that international record-sharing might be feasible in the context of a bipartite agreement between countries, such as the one that provides care for British citizens who spend their winters in Spain. “We don’t have the availability of treatment across borders yet,” he says, “Interoperability is meaningless if there is no provision for care.”
And then there are the issues of confidentiality and security. “If I were living six months out of the year in Spain, I wouldn’t necessarily want to have my health records online,” Bywater says. “But I would want to have my medication list online.” It also would be helpful for a foreign doctor to have information on chronic diseases or allergies, he adds.
Care before records
In some areas, access to care is a greater issue than interoperability or even basic information technology, says Joan Dzenowagis, a project manager with the World Health Organisation. While Dzenowagis witnessed this phenomenon first-hand while touring India, she says that it could equally apply to some of the less-developed Central European members of the EU.
“Given the choice between ICT and access, people are going to choose access every time,” Dzenowagis says.
Even in a single, large system like Kaiser Permanente in the US, interoperability is proving elusive. Kaiser is trying to build a common electronic health record for its 8 million patients and 12,000 physicians scattered across nine operational regions.
At the Geneva conference, EHR programme director Bruce Turkstra reported that the largest population Kaiser can exchange full medical information for is about 1.5 million to 2 million people. The rest just get health summaries, many of which are derived from payment claims rather than actual clinical data.
Fragmentation is prevalent even in Denmark, which has a total population of just 5.3 million, says Henrik Bjerregaard Jensen, chief executive of MedCom, the Danish national healthcare data network. But MedCom is overcoming barriers by cutting off bite-sized pieces.
Discharge and referral letters can be automated by interoperable messaging systems, Jensen says, and MedCom has done just that by specifying a single electronic form for each type of letter.
Since 1999, about 4,000 health institutions across Denmark with at least 100 different IT systems have built electronic messaging links are linked electronically, he says. Today, 81 per cent of e-prescriptions, 84 per cent of discharge orders and 97 per cent of lab reports traverse the MedCom network in standard format.
“Start with the basic needs,” Jensen advises.
Identification management is just emerging on the national level in most of Western Europe, says Dr Ramin Tavakolian of the Berlin-based Central Research Institute of Ambulatory Health Care in Germany, so full-fledged international projects simply are unrealistic in the near term.
Language
Ilias Iakovidis, deputy head of e-health in the EC’s Directorate General for Information Society and Media, says that mobility of the population across the EU is the “biggest nightmare” to those planning international interoperability of health information. Language and semantic barriers are among the myriad hurdles.
“The best way to address these problems is using a concept-based lexicon engine built upon a common pool of standardized, codified medical concepts,” says Theo Bosma, vice president of global sales for US-based Health Language Inc., who was in Geneva to present a session on clinical terminology.
The EC essentially is requiring every member state and some membership candidates to develop national plans for interoperability, through a Turkish-led programme called A Roadmap for Interoperability of eHealth Systems (RIDE). Iakovidis likens it to an international translation box since the participants have determined that is unrealistic to have one clinical data model for all of Europe.
Work on integration is happening at a governmental level within Europe. The EC’s e-health office is about half-way through a two-year project to determine how healthcare providers can issue a basic patient summary for use across borders.
Furthermore, the European Health Telematics Association (EHTEL) is attacking a single component — namely e-prescribing — as part of its Interoperability of Identification Management in eHealth (i2 Health) project. Based on a workshop on this topic in Amsterdam last March, i2 Health recommended “running demonstrators to achieve and prove cross-border interoperability,” following accepted European regulatory processes.
Both projects represent small but important steps along the road to international transition.
No, it's full of pure Medifola.